4
4
Relations avec les médias au niveau du groupe Roche
Téléphone: +41 61.688 8888 / E-Mail: basel.mediaoffice@roche.com
- Alexander Klauser (responsable du bureau des médias)
- Silvia Dobry
- Daniel Grotzky
- Štěpán Kráčala
Sources
1 Arzneimittel-Fachinformation unter www.swissmedicinfo.ch
2 Walling HW, Fosko SW, Geraminejad PA, et al. Aggressive basal cell carcinoma: presentation, pathogenesis, and management.
Cancer Metastasis Rev. Aug-Dec 2004; 23(3-4):389-402
3 National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™). Basal cell and
squamous cell skin cancers. Version 2.2012
4 Von Hoff DD, LoRusso PM, Rudin CH et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J
Med. Sep 2009;361(12):1164-1172
5 Telfer NR, Colver GB and Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol. Jul 2008;159(1):35-
48
6 Gilbody JS, Aitken J, Grenn A. What causes basal cell carcinoma to be the commonest cancer? Aust J Public Health. Jun1994;
18(2):218-21
7 Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. Sep-Oct 2010; 60 (5):277–300
8 Krebsliga Schweiz, Broschüre “Heller Hautkrebs: Basaliom, Spinaliom, Vorstufen”, 2008
9 Von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am
Acad Dermatol. Jun 1984;10(6):1043-1060
10 Mosterd K, Arits AH, Thissen MR, Kelleners-Smeets NW. Histology-based treatment of basal cell carcinoma. Acta Derm
Venereol. 2009;89(5):454-458
11 Wadhera A, Fazio M, Bricca G, Stanton O. Metastatic basal cell carcinoma: a case report and literature review. How accurate is
our incidence data? Dermatol Online J. Sep 2006;12(5):7
12 Ting PT, Kasper R, Arlette JP. Metastatic basal cell carcinoma: report of two cases and literature review. J Cutan Med Surg. Jan
2005;9(1):10-15
13 Wong CS, Strange RC, Lear JT. Basal cell carcinoma. BMJ. Oct 2003;327(7418):794-798.
14 Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, Kerl H. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol.
Dec 2007;157 Suppl 2:47-51.
15 Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. Nov 2005;353(21):2262-2269.
16 Sekulic A, Migden MR, Oro AE, et al. Efficacy and safety of vismodegib in advanced basal cell carcinoma (BCC): 12-month
update of the ERIVANCE BCC study, ESMO Sep/Oct 2012, Poster 1112PD
17 Sekulic A, Migden MR, Oro AE, et al., Efficacy and safety of vismodegib in advanced basal-cellcarcinoma. N Engl J Med. Jun2012;
366 (23): 2171-9